Thermo Fisher Scientific's organic sales growth accelerated sequentially to 6% in the third quarter, while reported growth reached 9%, including a net 3% contribution from acquisitions and divestitures. Management raised its full-year sales growth guidance to 7%-8%.
Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience.
Tariffs introduce uncertainty for the entire life science industry.
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.15 | 17.91 | 29.29 |
Price/Book Value | 4.68 | 2.08 | 6.80 |
Price/Sales | 5.47 | 2.97 | 6.83 |
Price/Cash Flow | 24.85 | 13.80 | 26.53 |
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Quick Ratio | 1.01 | 0.99 | 1.41 |
Current Ratio | 1.55 | 1.69 | 2.05 |
Interest Coverage | 5.57 | 7.22 | 16.08 |
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Return on Assets (Normalized) | — | 4.75% | 13.27% |
Return on Equity (Normalized) | — | 8.32% | 24.92% |
Return on Invested Capital (Normalized) | — | 6.65% | 16.95% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Danaher Corp
DHR
| LOCK|?Z@w?NTZ | LOCK|pM | $163B | |||
| Agilent Technologies Inc
A
| LOCK|@wzmPg$% | LOCK|v>^ | $50B | |||
| Waters Corp
WAT
| LOCK|$x!nl&y | LOCK|zQH | $46B | |||
| IQVIA Holdings Inc
IQV
| LOCK|hS^<%p | LOCK|&>X< | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|Lb<Kj&b | LOCK|Fj | $44B | |||
| Illumina Inc
ILMN
| LOCK|f!#kH!Y | LOCK|kjDz | $42B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|pGy<?>K | LOCK|?G<! | $34B | |||
| Labcorp Holdings Inc
LH
| LOCK|Lcfr^>?y | LOCK|k>$$> | $27B | |||
| Quest Diagnostics Inc
DGX
| LOCK|!kTs!$F | LOCK|@gFql | $27B |
United States